Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States

被引：36

作者：

Danesh, Melissa J. ^{[1
]}

Kimball, Alexa B. ^{[2
]}

机构：

[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

[2] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 01期

关键词：

anti-IL-17RA; brodalumab; depression; economic recession; monoclonal antibody; suicidal ideation; suicide; DOUBLE-BLIND; PSORIASIS; INCREASE; PLACEBO;

D O I：

10.1016/j.jaad.2015.08.057

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：190 / 192

页数：3

共 9 条

[1]

[Anonymous], UND CAUS DEATH 1999

[2]

Celgene Corporation, HIGHL PRESCR INF

[3] Increase in Suicides Associated With Home Eviction and Foreclosure During the US Housing Crisis: Findings From 16 National Violent Death Reporting System States, 2005-2010 [J].

Fowler, Katherine A. ;

Gladden, R. Matthew ;

Vagi, Kevin J. ;

Barnes, Jamar ;

Frazier, Leroy .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (02) :311-316

[4] Association of patient-reported psoriasis severity with income and employment [J].

Horn, Elizabeth J. ;

Fox, Kathleen M. ;

Patel, Vaishali ;

Chiou, Chiun-Fang ;

Dann, Frank ;

Lebwohl, Mark .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (06) :963-971

[5]

Papp K, 2015, 73 ANN AM AC DERM M

[6] Effects of Adalimumab versus Placebo on Risk of Symptom Worsening in Psoriasis and Subsequent Impacts on Health-Related Quality-of-Life Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled, Multicentre Clinical Trials [J].

Papp, Kim A. ;

Signorovitch, James ;

Ramakrishnan, Karthik ;

Yu, Andrew P. ;

Gupta, Shiraz R. ;

Bao, Yanjun ;

Mulani, Parvez M. .

CLINICAL DRUG INVESTIGATION, 2011, 31 (01) :51-60

[7] Increase in state suicide rates in the USA during economic recession [J].

Reeves, Aaron ;

Stuckler, David ;

McKee, Martin ;

Gunnell, David ;

Chang, Shu-Sen ;

Basu, Sanjay .

LANCET, 2012, 380 (9856) :1813-1814

[8] Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial [J].

Tyring, S ;

Gottlieb, A ;

Papp, K ;

Gordon, K ;

Leonardi, C ;

Wang, A ;

Lalla, D ;

Woolley, M ;

Jahreis, A ;

Zitnik, R ;

Cella, D ;

Krishnan, R .

LANCET, 2006, 367 (9504) :29-35

[9]

World Health Association, MORT DAT

← 1 →